Objectives: To assess the prevalence of statin usage, intensity of statin therapy, and serum LDL cholesterol levels achieved in clinical diabetes mellitus population to analyze whether the recommendations of American College of Cardiology/American Heart Association’s cholesterol guidelines 2013 (ACC/AHA cholesterol guidelines 2013) are achieved in them. Methods: Fasting lipid profile values, prevalence of statin usage, and intensity of statin therapy among 306 diabetes mellitus patients in the age group of 40 to 75 years, visiting the medicine department of a secondary care hospital, were noted. Results were analyzed as per the ACC/AHA cholesterol guidelines 2013 using Microsoft excel 2016. Results: Out of 294 diabetes mellitus patients who qualified for statin therapy, only 68% (199) are on statins. In this group of patients, 22% (44) are on low-intensity, 77% on moderate-intensity, and 1% (3) are on high-intensity statin therapy. When the serum LDL cholesterol levels of the diabetic patients were analyzed, only 21% (64) of them could achieve the level of < 70 mg/dl, below which the risk of developing cardiovascular disease is low. Conclusions: Dyslipidemia, a risk factor for the development and progression of atherosclerosis among diabetes mellitus patients, is not being treated in secondary care practice as per the ACC/AHA cholesterol guidelines of 2013. Initiating moderate-intensity statin therapy among non-statin users and shifting patients on low-intensity to moderate-intensity statin therapy would help these patients in achieving the desired serum LDL cholesterol level of < 70 mg/dl.
|Journal||International Journal of Diabetes in Developing Countries|
|Publication status||Published - 01-10-2020|
All Science Journal Classification (ASJC) codes
- Internal Medicine
- Endocrinology, Diabetes and Metabolism